Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 162, pseudogene (RN7SL162P)

Target
RN7SL162P
Molecular classification
Pseudogene, Non-coding RNA family, Signal recognition particle (SRP) RNA family (parental sequence relation)
01

Overview

RN7SL162P is a non-protein coding pseudogene related to the 7SL RNA gene, which encodes the RNA component of the *signal recognition particle* (SRP)—a ribonucleoprotein complex that plays an essential role in directing proteins to the endoplasmic reticulum in eukaryotic cells[5][7]. However, as a pseudogene, RN7SL162P does not produce functional 7SL RNA and is not known to be expressed or biologically active. Pseudogenes are common in the genome and usually lack functional roles, although rare examples of pseudogenes modulating cell biology through RNA-based mechanisms have been described. There is **no known evidence that RN7SL162P is a therapeutic target, biomarker, or drug-interacting gene**, nor is there any evidence for involvement in disease or direct biological processes[1][3][6]. **Notable context:** - This gene is sometimes cataloged in genomic databases due to sequence homology but is not considered biologically relevant for drug discovery, disease monitoring, or conventional molecular biology applications. - Its presence reflects evolutionary remnants of the functional SRP RNA sequence rather than an active molecular target. - If referencing SRP RNA as a target, be aware that *functional genes* (not pseudogenes) are involved in protein targeting and cellular compartmentalization[5][7].

Other names
RN7SL162P
02

Biological functions

No established biological function for RN7SL162P itself[1][3].Pseudogene transcripts from the 7SL family can generate small interfering RNAs which modulate innate immunity and retrotransposition in rare cases, but this is not confirmed for RN7SL162P specifically[3][4].
03

Disease associations

No known direct disease association for RN7SL162P[1][3].General pseudogenes (including 7SL family members) have been implicated in regulatory networks related to cancer and other diseases by acting as *miRNA decoys* or modulating gene expression in other family contexts—but these roles are speculative for RN7SL162P[4].

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 162, pseudogene (RN7SL162P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 162, pseudogene (RN7SL162P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call